prednisolone has been researched along with Myringosclerosis in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Myringosclerosis: The formation of dense connective tissue in the TYMPANIC MEMBRANE that does not necessarily cause or lead to loss of hearing.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Our objective is to evaluate the effectiveness of ciprofloxacin in the prevention of myringosclerosis that is created by myringotomy in rats and to compare it with prednisolone." | 7.78 | Evaluation of the effectiveness of topical ciprofloxacin and prednisolone in the prevention of myringosclerosis. ( Arslan, N; Caydere, M; Demirci, M; Oguz, H; Taştan, E; Tepe, D; Ustun, H, 2012) |
| " Our objective is to evaluate the effectiveness of ciprofloxacin in the prevention of myringosclerosis that is created by myringotomy in rats and to compare it with prednisolone." | 3.78 | Evaluation of the effectiveness of topical ciprofloxacin and prednisolone in the prevention of myringosclerosis. ( Arslan, N; Caydere, M; Demirci, M; Oguz, H; Taştan, E; Tepe, D; Ustun, H, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arslan, N | 1 |
| Tepe, D | 1 |
| Taştan, E | 1 |
| Demirci, M | 1 |
| Caydere, M | 1 |
| Ustun, H | 1 |
| Oguz, H | 1 |
1 other study available for prednisolone and Myringosclerosis
| Article | Year |
|---|---|
Evaluation of the effectiveness of topical ciprofloxacin and prednisolone in the prevention of myringosclerosis.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Ciprofloxacin; Di | 2012 |